EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma

Ramin Zargham iD, Feng Selina Ji iD, Tarek Bismar iD

Diagnostic Cytopathology · 2026

DOI: 10.1002/dc.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2026. Verfasst von Ramin Zargham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Transcription Factors, Lung Neoplasms, DNA-Binding Proteins. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alberta Precision Labs, Alberta Precision Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐small cell lung carcinomas, not otherwise specified (NSCLC‐NOS) with a specific signature including high‐grade hepatoid/clear cell morphology, negative lung panel mutational analysis, negative TTF‐1/Napsin A staining can be reported as a morphologic variant of an aggressive carcinoma with loss of one of the subunits of the SWI/SNF‐chromatin complex. However, this entity is often underdiagnosed, and the specific percentages of each subunit affected remain unclear. In this study, we used immunomarkers for common major (BRG1 and BRM) and minor subunits (ARID1B, ARID1B, and ARID2) in suspicious cases in a retrospective method. Our study revealed that 90% (62 out of 69 cases) of the cases exhibiting the abovementioned signature showed loss of one of the common SWI/SNF complex subunits, with BRG1 and ARID1B being the most lost subunits. We suggest that the combination of hepatoid or clear cell cytomorphology, negative TTF1/Napsin A, and negative lung panel mutational analysis should trigger immunohistochemical examination of SWI subunits expression. The uniqueness of this study lies in the large number of cases, with their specimens obtained via cytopathological methods and immunostained with all five common SWI markers. This study contributes to the familiarity and awareness of pathologists and oncologists by highlighting the importance of cytomorphology and immunohistochemical profile of SWI/SNF‐deficient NSCLC‐NOS, facilitating earlier diagnosis, and may ultimately lead to more specific and novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungTranscription FactorsLung NeoplasmsDNA-Binding ProteinsHumansNuclear ProteinsBiomarkers, TumorThyroid Nuclear Factor 1DNA HelicasesFemaleMaleMiddle Aged

Stichwörter der Autor:innen

ARID1BBRG1NSCLCSMARCA4 fine needle aspiration (FNA)SWI/SNF complexcytopathology

Substanzen

Transcription FactorsDNA-Binding ProteinsTTF1 protein, humanNuclear ProteinsBiomarkers, TumorThyroid Nuclear Factor 1DNA HelicasesARID1B protein, humanSMARCA4 protein, humanARID2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Ramin Zargham, Feng Selina Ji, Tarek Bismar

Förderung

  • Alberta Precision Labs
  • Alberta Precision Laboratories

Zitieren

APA

Zargham, R., Ji, F. S., & Bismar, T. (2026). Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70084

Vancouver

Zargham R, Ji FS, Bismar T. Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70084

BibTeX
@article{Zargham2026,
  author = {Zargham, Ramin and Ji, Feng Selina and Bismar, Tarek},
  title = {Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  doi = {10.1002/dc.70084}
}
Kostenlos starten →